Located in 64 countries with 68,000 employees, Lafarge is a world leader in building materials with top-ranking positions in its Cement, Aggregates & Concrete businesses. In 2011 Lafarge posted sales of 15.3 billion euros.
For the second year in a row, Lafarge ranked amongst the top10 of 500 companies evaluated by the “Carbon Disclosure Project” in recognition of its strategy and actions against global warming. With the world’s leading building materials research facility, Lafarge places innovation at the heart of its priorities, working towards sustainable construction and architectural creativity.
Additional information is available on the web site at www.lafarge.com
Health at Lafarge - A number one priority
Lafarge ranks health as its top priority and has maintained the same ambition for over 10 years: to be among the safest and the healthiest companies in the world. To achieve this goal, the Group focuses on:
Maintaining employees' health
Lafarge has developed a health strategy for all its sites which is based on three pillars:
Acting locally for everyone's health
Lafarge is also involved in public health initiatives. This approach dates back to 2001 when the Group implemented its first HIV/AIDS prevention and treatment program in sub-Saharan Africa.
Since then, the Group takes advantage of this positive experience to enlarge its programs to other illnesses and to adapt them to local issues, such as the fight against malaria or tuberculosis in African countries and diabetes and alcohol-related issues in Europe and North America. And in some countries where access to medical and healthcare facilities is more difficult, Lafarge goes beyond its plants to make its health programs available to local community members.
Fighting AIDS for employees and communities
Lafarge committed to fighting AIDS in the region in 2001. It was the first French company to join the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria (GBC) in 2002.
Lafarge set up the Pilot Project in 2002, which evaluated the impact of HIV/AIDS on Lafarge's business in sub-Saharan Africa. It established best practices and guidelines for management teams and employees.
In 2003, Lafarge published its HIV/AIDS Guidelines, which implemented nondiscrimination and confidentiality policies. The Group formulated these guidelines in collaboration with:
Lafarge created two Road Maps based on local best practices and the experience of Private Investors for Africa member companies. The Road Maps monitor and evaluate the Group's HIV/AIDS and Malaria program.
Lafarge's HIV/AIDS program includes:
As a result of these measures, in 2007:
The success of Lafarge's HIV/AIDS program is largely due to partnerships with unions, families, schools, companies, governmental organizations and NGOs. The Group has expanded its workplace program to local communities through partnerships with:
Since 2003, Lafarge has worked alongside CARE, one of the largest human development NGOs, in the struggle against HIV/AIDS. CARE is a member of Lafarge's Africa Health Committee, which selects indicators, coordinates actions and shares best practices. In addition to a CARE representative, the committee includes a health coordinator from each subsidiary, a Group representative, and a medical adviser.
Using anti-AIDS methodology to fight malaria
Malaria kills one person every 30 seconds and significantly hampers Africa's economic development. It causes on average a third of Lafarge employee absenteeism in Africa. The Group has been combating the disease since 2006. Lafarge has developed a malarial prevention and health program inspired directly by the methodology used to combat AIDS, which includes:
Lafarge's partners in the fight against malaria include: